|
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
p-Toluidine |
CAS 106-49-0 | ||
CH3C6H4NH2 |
RTECS XU3150000 | ||
|
Synonyms & Trade Names 4-Aminotoluene, 4-Methylaniline, 4-Methylbenzenamine, 4-Toluidine, p-Tolylamine |
DOT ID & Guide 1708 153 |
||
Exposure
|
NIOSH REL: Ca See Appendix A | ||
| OSHA PEL†: none | |||
| IDLH Ca [N.D.] See: IDLH INDEX | Conversion | ||
|
Physical Description White solid with an aromatic odor. [Note: Used as a basis for many dyes.] |
|||
|
MW: 107.2 |
BP: 393°F |
MLT: 111°F |
Sol: 0.7% |
|
VP(108°F): 1 mmHg |
IP: 7.50 eV |
|
Sp.Gr: 1.05 |
|
Fl.P: 188°F |
UEL: ? |
LEL: ? |
|
| Combustible Solid | |||
|
Incompatibilities & Reactivities Oxidizers, acids |
|||
|
Measurement Methods NIOSH 2002; OSHA 73 See: NMAM or OSHA Methods |
|
Personal Protection & Sanitation (See protection) Skin: Prevent skin contact Eyes: Prevent eye contact Wash skin: When contaminated/Daily Remove: When wet or contaminated Change: Daily Provide: Eyewash, Quick drench |
First Aid (See procedures) Eye: Irrigate immediately Skin: Soap wash immediately Breathing: Respiratory support Swallow: Medical attention immediately |
|
Important additional information about respirator selection Respirator Recommendations NIOSH At concentrations above the NIOSH REL, or where there is no REL, at any detectable concentration: (APF = 10,000) Any self-contained breathing apparatus that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode (APF = 10,000) Any supplied-air respirator that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode in combination with an auxiliary self-contained positive-pressure breathing apparatus Escape: (APF = 50) Any air-purifying, full-facepiece respirator (gas mask) with a chin-style, front- or back-mounted organic vapor canister having an N100, R100, or P100 filter. Click here for information on selection of N, R, or P filters./Any appropriate escape-type, self-contained breathing apparatus |
|
| Exposure Routes inhalation, skin absorption, ingestion, skin and/or eye contact | |
| Symptoms Irritation eyes, skin; dermatitis; hematuria (blood in the urine), methemoglobinemia; cyanosis, nausea, vomiting, low blood pressure, convulsions; anemia, lassitude (weakness, exhaustion); [potential occupational carcinogen] | |
|
Target Organs
Eyes, skin, blood, cardiovascular system Cancer Site [in animals: liver tumors] |
|
| See also: INTRODUCTION See ICSC CARD: 0343 |